Pharmaceuticals, Biotechnology and Life Sciences
LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTC PINK: FRLI) (“Frelii” or “the Company”) today announced the details of its recent agreement with…
DUBLIN–(BUSINESS WIRE)–The “Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration…
DUBLIN–(BUSINESS WIRE)–The “Global Microbiome Partnering Terms and Agreements 2014 to 2019” report has been added to ResearchAndMarkets.com’s offering. The Global…
Results from DARZALEX® ▼ (daratumumab) Phase 3 CASSIOPEIA study in newly diagnosed transplant eligible patients with multiple myeloma selected for…
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as…
Multi-year research collaboration and software agreement reimagines the discovery and clinical development of medicines through data sciences CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference,…
Pediatric Scientific Data for the Omnipod Horizon System Presented at the American Diabetes Association’s 79th Scientific Sessions ACTON, Mass.–(BUSINESS WIRE)–Insulet…
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…